FindTrial
Sign In

Reinforcing Kidney and Activating Blood Circulation and Resolving Phlegm Therapy Improving Quality of Life for Hypertension in the Elderly

Reinforcing Kidney and Activating Blood Circulation and Resolving Phlegm Therapy Improving Quality of Life for Hypertension in the Elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006733
Enrollment
Unknown
Registered
2015-06-25
Start date
2015-07-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in the elderly

Interventions

experimental group:Reinforcing Kidney and Activating Blood Circulation and Resolving Phlegm Therapy plus AMLODIPINE BESYLATE
control group:AMLODIPINE BESYLATE

Sponsors

First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) corresponding to diagnostic criteria of hypertension (grade1 and grade 2); (2) 60~80 years old; (3) freely given informed consent

Exclusion criteria

Exclusion criteria: (1) accelerated hypertension,secondary hypertension(renal hypertension,primary aldosteronism,phaochromocytoma, hypercortisonism,aortic coarctation) excluded; (2) Severe chronic obstructive pulmonary disease excluded; (3) ALT>300U/L, AST>200U/L; (4) diabetes mellitus which blood glucose is not controled steadly; (5) peptic ulcers with active; (6) serious heart,kidey, brain diseases; (7) depression; (8) cancer; (9) HIV; (10) mental disorders; (11) Non-compliant patient; (12) Taking part in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Blood presure;SF-36;—

Countries

China

Contacts

Public ContactShaoxiang Xian
zhongyfy@126.com+86 020 36591692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026